Member Info for Aldebaran

JHFH, im trying to manipulate people? You're the one wrongly asserting AGAIN. I'm here because this is my biggest nest egg. So you seemingly are ok to say that and I cant counter with, no its not, avacta is without you and the other hemo ultras losing there minds?

Also, yes compare market caps but also compare chance of success and target market. Avacta TAM is now in the region of 400bn. You can scoff and laugh all you like. That is the reality. So the opportunity is proportionally bigger than hemo even though avacta start with a larger market cap than hemo.

Hence why avacta is my biggest nest egg. Not hemo. So you are wrong and im happy to point out when your wrong. I only have a bit in here as a safety next almost because you just never know with anything what can go wrong. Risk is what is left over after you THINK You have thought of everything. Like you do here yet you aren't event aware of allogenic CAR-T backed up with CRISPR knocking out the TCR.

I like hemo, I see the upside but it simply is not a patch on avacta as you would see if you actually bothered to research it even half properly. Upto you, do or dont im past caring but dont say false things like im only here because I am obsessed with hemo and that its my biggest nest egg because neither of those points are true

Ive heard it all now. Lower share prices are a good thing 😅🤥

Bonkers but if you really do think that, then you'll be pleased to know these are heading for 5p.

JHFH I can assure you 2 things.

1 I am not obsessed with hemo

2 it is absolutely not the biggest nest egg, not even close to the upside potential of Avacta

So your wrong. Again. As always actually.

We will get one. Obviously. How can they do an explainer in the middle of the 2nd conference?

Explainer comes after AACR and appears to me at least something commercial is lined up ready.

What's more is the should be science day to luck forward too. And. P1b data release and webinar also in November. I think p1b data release is also pivotal as we will be finding out who is funding p2. Big 2 months here kicking of today

Back to back conferences how they gonna find time to put on a investor event come on lad behave. Aacr is only a matter of days, so they'll do esmo, then aacr starts the day after lasts 4 days itself and then they will do a investor webinar bringing us highlights from both.

Clearly

Shortly after esmo yea ok but with back to back conference then that could and probably does mean after aacr. Im expecting a deal to be announced and then the webinar goes through all the details and scientific updates from both conferences on week commencing 27th October.

Still need to squeeze in a science day plus p1b data readout after that and before the Xmas slowdown so not a lot of room for trading in and out which could COULD lead to a much higher rapid and sustained rise.

This company really ought to be valued over 1bn with a third party validation

ESMO is safety data from p1a. We already know its exceptional and they've lost the cardiotox. It'll be interesting to see the pfs of SGC also.

Aacr is where i think we'll see a deal as the dual warhead will be presented there. Wear literally days away now.

There as been a seller, I thought this would get to around 85p before stalling but no matter as the seller has been almost matched with buyers so price forming a nice base around the 70p level which is fair for how high its moved in the time frame. I see pullbacks as buying ops and news will be released next week that sees the next leg up and towards £1 per share, or beyond depending just how good that news is.

Lol funny dat pumpkin

People spout a lot of shhh it on these bulletins boreds about buying but price action shows what they are doing. Say one thing and do another which is why its important to learn and read price action.

Someone knew or there as been some forward selling. How many more is their?

Market is so bent

Livedataaccountant I called the price pullback to 64p and only just missed it at 65p. Avacta are putting in a series of higher highs and higher lows. The higher highs are made on increasing volume where lower lows on decreasing volume. 200, 100 and 50dma all pointing up and in correct order. The 100dma has also crossed the 50dma.

In a nutshell all incredibly bullish. Buy the pullback territory. Price action is perfectly aligned with fundamentals. I see £1 here shortly which will have inevitable resistance but as always news trumps technicals. The right kind of news could see this rally STRONGLY and of course if we partner with someone like Robinsons for Ribena then price could also crash.

Right now, looking great. Pullbacks are for buying in uptrends. Not shhhh itting the bed. The newbies hear will do well to remember that

Thanks Haywain and I agree. Archbishop brought it up, again, not me.

Only thing I do think IS useful is just to compare hemo to other biotechs from time to time. Especially what I like is avactas R&D spotlight series. Not ramping avacta im just saying its really useful and engaging and it costs nothing. I want HEMO to be better thats all.

It has the core right i.e. the science. Now it needs to build around that and drive shareholder value and some other biotechs do have better ways to do certain things so its useful to compare and get ideas etc.

Just to clarify one final final time I love hemo tech. I believe its on the verge of a paradigm shift in the treatment of rr AML and I believe the company to be undervalued. Even if I come across as negative some times or most times its only cos I can see so many opportunities for improvements that hemo aren't taking. Its annoying me as an INVESTOR. If I was trading this, id be gone by now. Believe it or not. Thats the truth. Au revoir for now

Archbishop you are absolutely right about Avacta. Please always remember you had the chance to buy shares in them at just over 50p and think of me when you do. Theyre 73p now and rising mind. Like you rightly say its over hyped ancient chemotherapy.

If its so good why are Saudi not using them for yet ANother One of their mega projects?

https://www.saudigulfprojects.com/2025/10/saudi-arabian-refineries-and-go-energy-to-develop-green-hydrogen-project/

I posted last week this looked like pulling back to 64p.

Its hit 65p today and someone appears to be gobbling up 10k blocks. Conferences start tomorrow.

Suspect pullback complete, chart ready for next leg up towards £1 IMO. Currently 68.5p bargain

JHFH, he will need money again but even if he doesn't. This is a PLC, not a private science experiment. He is accountable to shareholders. He should be publishing plans and timelines that investors can then hold him to account.

You dont just give him a bag of cash then let him get on with it. Even private companies have objectives and goals etc... its normal practice.

Shareholders all have different timelines. How do you differentiate between a investor and a trader? Hold for 1 week your a trader, 1 month trader, 6months mmmmm still a trader. 1 year or more, That's a reasonable investment timeline.

You yourself traded and sold shares recently did you not?

What your saying is people should buy with no visibility of any timelines, just trust vlad is doing a brilliant job and not sell any shares until the takeover or a set period of time has passed that you can deem them to be worthy investors and not dirty traders.

Do me a favour!

Again, traders read price. I can. I also invest. Not everyone just goes all in on one stock and wants to hold forever.

So, vlad will need money again, especially if this gets to p2 and he wants to progress CBR etc... I doubt very much if you and your mates or the warrants have the hundreds of millions required to help so he needs to be proactive and communicate to the market that is paying his wages

Hemo is undervalued.

HG-CT-1 has huge potential.

Trial results so far at lowest dose are highly encouraging.

All the above is true.

Doesn't mean that the following isnt also true

Competitors and innovation is a threat

Speed is slow

Vlad is a poor CEO

communications are awful

By the way Archbishop I wouldn't help you with anything so no point asking. Just know I read a very interesting paper last night and im sure there is some fantastic technology on the horizon. And your right about avacta. Trust in your research and stay well away from that dud.

Will you bore off with the paranoia about traders and shorters JHFH for the love of God man give it up. Traders can read price they are in and out of stocks all the time. You think they are experts in bioscience one moment, then gold mining the next and sophisticated financial software after that? No. They read price.

I tell you who do want a roadmap. Investors. Especially institutions. You should of took hemo private at 7m market cap cos thats how you behave. Operate totally in the dark then one day announce a takeover. This is a PLC and better comes are sorely needed. Another reason why other stocks such as the one that shall not be named have market caps at multiple of hemo's.

I just want a roadmap JHFH. I mean we haven't even had a webinar since the DC and NYC conferences etc.. its poor. We're in the dark. You guys seem to accept that and have got so used to it you think its normal. Its not. Its really not.

Hemo have something potentially very special hence why I am here.

What I want is a trial roadmap I dont think thats to much to ask for. Trial data is what will ignite big pharma in my view

By the way i am bullish here for the tech. My point is that it needs to be commercialised ASAP. and I dont mean with some non binding agreement in Estonia I mean something material. Hopefully q1 2026 is when it comes and not later. Other tech is catch up and there are risks everywhere. Sooner this is brought out the better

Thats true Haywain however with gene editing to knock out TCR then what?

This is what other companies are doing. NOW.

You slate avacta for having "ancient chemo" yet there precision chemo its chalk and cheese compared to normal chemo as it as now side affects.

Now could say allogenic CAR-T with CRISPR makes autologous CAR-T look like antique CAR-T.

People here have no clue they are relying on you for there scientific research.

And im supposed to be just a tinpot small time trader desperate for news to trade lmao.

This bored is so biased and blinded and in love with hemo its unbelievable.

Vlad needs to get a SERIous move on and commercialise this tech. He needs to provide a clear roadmap for INVESTORS also.